Boulder, CO, United States of America

Soren Mogelsvang

This inventor holds 5 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Serpin Pharma, LLC. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Soren Mogelsvang. Retrieved from https://idiyas.com/inventor/soren-mogelsvang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 100.0


 

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 10(Granted Patents)


Location History:

  • Herndon, VA (US) (2015 - 2018)
  • Boulder, CO (US) (2019 - 2021)

Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Soren Mogelsvang: Pioneering Peptide Research

Introduction

Soren Mogelsvang is a prominent inventor based in Boulder, Colorado, recognized for his significant contributions to peptide research. With an impressive portfolio of five patents, he has made notable strides in the treatment of various medical conditions, focusing on autoimmune, inflammatory, and metabolic diseases.

Latest Patents

Mogelsvang's latest patents include "Serpin peptides and methods of using the same," as well as "Peptides and methods of using the same." These patents detail innovative peptide formulations and their applications in treating complex diseases. His research aims to provide novel therapeutic options and improve patient outcomes in diverse medical conditions.

Career Highlights

Throughout his career, Soren has demonstrated a commitment to advancing the field of biotechnology. His work at Serpin Pharma LLC, a company dedicated to clinical advancements and peptide research, highlights his focus on practical applications of his inventions. His extensive research efforts underscore his role as a leader in the scientific community.

Collaborations

Soren collaborates closely with Cohava Gelber, sharing insights and expertise to further their research objectives. This partnership exemplifies the collaborative nature of innovation, where knowledge exchange leads to new discoveries and breakthroughs in the field.

Conclusion

Soren Mogelsvang stands out as an innovative inventor whose work with peptide technologies is paving the way for advancements in medical treatments. His dedication to research and collaboration continues to influence the biotechnology landscape, making significant contributions to the understanding and treatment of diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…